These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9607389)

  • 41. [Valley/peak ratio and pressure changes during treatment with fosinopril in hypertensive elderly patients].
    Cicconetti P; Salza MC; Rizzo V; Bianchi A; Capponi L; Marigliano V
    Clin Ter; 1996; 147(7-8):359-64. PubMed ID: 9118617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension.
    Migdalis IN; Gerolimou B; Kozanidou G; Hatzigakis SM; Karmaniolas KD
    J Med; 1997; 28(5-6):371-80. PubMed ID: 9604795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension.
    Tuncer M; Gunes Y; Guntekin U; Gumrukcuoglu HA; Eryonucu B
    Adv Ther; 2008 Feb; 25(2):99-105. PubMed ID: 18297254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
    Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
    Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
    Trivedi H; Lal SM
    Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effectiveness and tolerance of fosinopril. ACE inhibitor therapy of hypertensive patients in general practice--clinical observation].
    Fassbinder W; Ziegler J
    Fortschr Med; 1997 Dec; 115(34):47-8. PubMed ID: 9465477
    [No Abstract]   [Full Text] [Related]  

  • 50. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center.
    Gates R; Cookson T; Ito M; Marcus D; Gifford A; Le TN; Nguyen CN
    Am J Health Syst Pharm; 2006 Jun; 63(11):1066-8. PubMed ID: 16709894
    [No Abstract]   [Full Text] [Related]  

  • 52. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
    Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
    Kirichenko AA; Ebzeeva EIu
    Kardiologiia; 2002; 42(10):36-40. PubMed ID: 12494055
    [No Abstract]   [Full Text] [Related]  

  • 55. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril.
    Leonetti G; Trimarco B; Collatina S; Tosetti A
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):230S-235S. PubMed ID: 9366278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of losartan and fosinopril in hypertensive type 2 diabetic patients.
    Kavgaci H; Sahin A; Onder Ersoz H; Erem C; Ozdemir F
    Diabetes Res Clin Pract; 2002 Oct; 58(1):19-25. PubMed ID: 12161053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A meta-analytical comparison of atenolol with angiotensin-converting enzyme inhibitors on arterial stiffness, peripheral blood pressure and heart rate in hypertensive patients.
    Xie H; Luo G; Zheng Y; Peng F; Xie L
    Clin Exp Hypertens; 2017; 39(5):421-426. PubMed ID: 28534649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.
    Schiffrin EL; Deng LY
    Hypertension; 1995 Apr; 25(4 Pt 2):699-703. PubMed ID: 7721419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.